Some nice stats I pulled up: Oh god.... Just click links in

New Post Public Reply Private Reply Replies (0) Message Board
Meach

Some nice stats I pulled up:
Oh god.... Just click links in the WWW. format- my stupid typing got stuck in hyperlink format which I didnt want===

little background:
http://www.fda.gov/Drugs/DevelopmentApprovalP...082378.htm

http://www.fda.gov/Drugs/DevelopmentApprovalP...efault.htm

http://www.fda.gov/downloads/AboutFDA/Working...239233.pdf

Interesting... more snooping...
http://www.accessdata.fda.gov/scripts/cdrh/cf...ma_pas.cfm
Doesnt say bmsn though... This is where it will appear when clinical hold is released

This is nice:  Talks about the rules surrounding INFORMATION ammendments:
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.31

This is probably more likely our ammendment;  Im assuming its due to the clinical patients we need that we are stuck?  clinical procedure ammendment:
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.30

I'm unsure, but it seems to me as though the IND # "to be" with bmsn is the number they have stated...  They need to amend all of this information--  It may  be after I have now read up on the IND process and everything therein that they are simply making all the information correct and current?
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.23

Information on CLINICAL HOLDS:
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.42

Any finally: I Spent the time checking out wtf is going on with share price- Where we should be at, etc, etc.

Right now:  1c.  That is where we should be.  We should not be moving beyond .008 or .012, but we are.  That's too bad.  Hold your money for now.

My calculation based off of every single other company who has been granted FDA approval (scaling down due to share structure etc)----- Once we hit phase 1 or 2 we will be at 11.7 cents (or .117).  I think thats somewhere at the end of 1 and beginning of 2.  Upon completion I'm thinking .25~~....)
And with the gene silencing tech, who knows.
Nonetheless-  This isnt short.
Small rewards on the short front- However; I might start shorting 50% of the pile, hell, who knows when news strikes.
In two years we'll be laughing (to say its legitimate)

In conclusion:  No fucking clue.

Is BMSN a scam? No idea.
Is BMSN fully 100% legitimate: No idea
Does HemaXellerate even exist?:  No idea
Is there proof that BMSN and the FDA are in contact and know of eachothers existence?: YES.
But I will know on Monday or Tuesday and we can save ourselves some face or laugh at my absurd paranoia.

I was trying to find out if BMSN was a scam or not, but i'm not finding any GRIEVOUS errors here... most other BMSN-LIKE companies who started out similarily in the past have equal disclosure, in fact one- pluristem theraputics inc, had their CEO go to jail for share manipulation lol-  thats what might happen to Koos soon....

Not that i've been shooting out emails and whatnot im a little concerned- no way in hell im selling though.

I have been forwarded to another agency within the FDA for my questions regarding BMSN and HemaXellerate------ WE WILL SEE WHAT HAPPENS.

Hopefully I'll get news mon or tues from then.

Til' then its beautiful and I'm off to enjoy the weekend.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 295

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 112

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 98

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 176

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Merit Medical Systems: Price Target Raised Amid Strong Growth Prospects

Updated Category News Views 92

Merit Medical Systems Price Target Increased by Baird Baird has enhanced its price target for Merit Medical Systems, Inc. (NASDAQ: MMSI) from $96.00 to $107.00, keeping an Outperform rating on the stock. This adjustment anticipates that the company will surpass its organic growth rate and earnings per share (EPS) expectations for the upcoming quarter. Confidence in Future...

Continue Reading
Qualifacts Is Enhancing Collaborative Workspaces in Tampa

Updated Category News Views 122

Qualifacts Consolidates Tampa Operations into a Modern Office Qualifacts, a prominent player in the field of electronic health records (EHR) and data solutions tailored for behavioral health and human services organizations, has made a significant move by consolidating its two smaller offices in Tampa. The company has transitioned into a new, modern location designed to...

Continue Reading
Unlocking the Potential of Neuromarketing for Digital Strategies

Updated Category News Views 140

Understanding Neuromarketing and Its Impact In today's competitive landscape, businesses are continuously seeking ways to enhance their digital marketing strategies. One approach gaining momentum is neuromarketing, which delves into the psychology behind user behavior. A recent article from Digital Silk explores how neuromarketing principles can guide organizations in...

Continue Reading
Monkee's of Loudoun Opens to Cheers and Elegance

Updated Category News Views 187

Bringing Southern Charm to Loudoun We've all seen those places where people parade in with snooty airs and pricetags that could feed a family for a week, but this one feels different. Monkee’s of Loudoun isn’t just rolling in the racks of high fashion — it’s bringing the allure of the South with a sprinkle of luxury and empathy. This franchise is no amateur,...

Continue Reading
PG&E Critiques Senate Bill 492's Wildfire Solutions

Updated Category News Views 60

PG&E's Take on Senate Bill 492: More to Be Desired Sit down for a moment, because PG&E's not mincing words with their latest statement. Talking about Senate Bill 492, PG&E puts it plain and clear—this legislation is just skirting around the edges of what's really needed to tackle California's wildfire crisis. In their eyes, it's like putting a band-aid on a wound that...

Continue Reading